Stock CASI CASI PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. CASI Pharmaceuticals, Inc.

Equities

CASI

KYG1933S1012

Market Closed - Nasdaq
Other stock markets
 03:58:16 2024-05-03 pm EDT 		5-day change 1st Jan Change
2.795 USD +4.29% Intraday chart for CASI Pharmaceuticals, Inc. +15.50% -60.96%
Mar. 28 CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 05 Top Midday Gainers MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Raises Price Target on CASI Pharmaceuticals to $12 From $10, Keeps Buy Rating
MT
BTIG Adjusts CASI Pharmaceuticals' Price Target to $10 From $21, Keeps Buy Rating
MT
CORRECTION : BTIG Lowers CASI Pharmaceuticals' Price Target to $21 From $40, Buy Rating Kept
MT
HC Wainwright Lowers CASI Pharmaceuticals' Price Target to $12 From $30, Buy Rating Maintained
MT
Oppenheimer Adjusts CASI Pharmaceuticals' Price Target to $35 From $6 After Reverse Stock Split, Maintains Outperform Rating
MT
BTIG Raises CASI Pharmaceuticals' Price Target to $21 From $40, Buy Rating Kept
MT
HC Wainwright Adjusts CASI Pharmaceuticals' Price Target to $3 from $4, Keeps Buy Rating
MT
CASI PHARMACEUTICALS : BTIG Initiates CASI Pharmaceuticals at Buy Rating With $4 Price Target
MT
CASI PHARMACEUTICALS : HC Wainwright Adjusts CASI Pharmaceuticals PT to $4 From $3.50, Maintains Buy Rating
MT
CASI PHARMACEUTICALS : Mizuho Security Initiates Coverage on CASI Pharmaceuticals With Buy Rating, $3.80 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CASI Stock
  4. News CASI Pharmaceuticals, Inc.
  5. Analyst Reco.